SEC Form 4 · accession 0001209191-18-019742
Vaxart, Inc. · VXRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Tucker
Officer — Chief Scientific Officer
Period of report
Mar 12, 2018
Accepted (ET)
Mar 14, 2018 · 9:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000072444
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 12, 2018 | M | 2,013 | $6.49 | A | 47,653 | D | |
| Common Stock | holding | — | — | — | 9,060 | I | By spouse | |
| Common Stock | holding | — | — | — | 25,388 | I | By joint trust with Frances Chang and Sean Tucker |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.49 | Mar 12, 2018 | M | 2,013 | D | — | Mar 13, 2018 | Common Stock | 2,013 | 0 | D |
Explanation of responses
- F1The option is fully vested.